Author information:
(1)Department of Urology, Medical University of Vienna, Währinger Gürtel 18-20, 
1090, Vienna, Austria.
(2)Department of Urology, The Jikei University School of Medicine, Tokyo, Japan.
(3)Research Center for Evidence Based Medicine, Tabriz University of Medical 
Sciences, Tabriz, Iran.
(4)Deaprtment of Urology, PRES Centre Val de Loire, CHRU Tours, France, 
Université François Rabelais de Tours, Tours, France.
(5)Department of Urology, King Fahad Specialist Hospital, Dammam, Saudi Arabia.
(6)Institute for Urology and Reproductive Health, Sechenov University, Moscow, 
Russia.
(7)Department of Urology, University Medical Center Hamburg-Eppendorf, Hamburg, 
Germany.
(8)Division of Urology, Department of Special Surgery, The University of Jordan, 
Amman, Jordan.
(9)Cancer Prognostics and Health Outcomes Unit, University of Montreal Health 
Centre, Montreal, Canada.
(10)Department of Urology, Medical University of Vienna, Währinger Gürtel 18-20, 
1090, Vienna, Austria. shahrokh.shariat@meduniwien.ac.at.
(11)Institute for Urology and Reproductive Health, Sechenov University, Moscow, 
Russia. shahrokh.shariat@meduniwien.ac.at.
(12)Division of Urology, Department of Special Surgery, The University of 
Jordan, Amman, Jordan. shahrokh.shariat@meduniwien.ac.at.
(13)Department of Urology, Weill Cornell Medical College, New York, NY, USA. 
shahrokh.shariat@meduniwien.ac.at.
(14)Department of Urology, University of Texas Southwestern, Dallas, TX, USA. 
shahrokh.shariat@meduniwien.ac.at.
(15)Karl Landsteiner Institute of Urology and Andrology, Vienna, Austria. 
shahrokh.shariat@meduniwien.ac.at.
(16)Department of Urology, Second Faculty of Medicine, Charles University, 
Prague, Czech Republic. shahrokh.shariat@meduniwien.ac.at.
(17)European Association of Urology Research Foundation, Arnhem, Netherlands. 
shahrokh.shariat@meduniwien.ac.at.